--- title: "POET Technologies Shares Slide Monday: What's Going On?" type: "News" locale: "en" url: "https://longbridge.com/en/news/286785170.md" description: "POET Technologies Inc. shares fell 4.70% to $15.23 on Monday as traders evaluate the company's AI data-center partnerships and commercialization updates. The company announced a $50 million initial purchase order from Lumilens and a $400 million direct offering tied to 19.05 million shares. Despite a 239.79% increase over the past year, the stock is experiencing volatility, with key resistance at $20.81 and support at $11.03." datetime: "2026-05-18T13:54:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286785170.md) - [en](https://longbridge.com/en/news/286785170.md) - [zh-HK](https://longbridge.com/zh-HK/news/286785170.md) --- # POET Technologies Shares Slide Monday: What's Going On? **POET Technologies Inc** (NASDAQ:POET) shares are trading lower Monday morning as traders keep assessing the company's AI data-center partnership narrative and recent commercialization updates around its optical interposer platform. - POET Technologies shares are climbing with conviction. Why is POET stock up today? ## What Is Driving POET Technologies’ Recent Momentum? POET is seeing more volatility as traders focus on commercialization signals, including a $50 million initial purchase order from Lumilens and a roadmap to more than $500 million in cumulative purchases over five years, highlighted in a $50 million initial phase. The same update cycle also included work with LITEON Technology and Lessengers on a 1.6T 2×DR4 optical transceiver module aimed at AI clusters and hyperscale data centers. POET's tape has also had to absorb financing overhang after the company announced a $400 million registered direct offering tied to 19.05 million common shares plus matching warrants at a combined $21 purchase price, as a $400 million raise took center stage. Those warrants are exercisable for three years at $26.15, and the company said proceeds are earmarked for manufacturing expansion, acquisitions, R&D and scaling initiatives. ## Critical Price Levels To Watch For POET Stock After a 239.79% run over the past 12 months, POET is still trading well above its major trend gauges: about 60.7% above the 20-day SMA ($11.03) and roughly 166.3% above the 200-day SMA ($6.66). That kind of separation often signals strong trend control, but it also raises the odds of sharp pullbacks if momentum cools. MACD is the cleaner momentum lens here: it's above its signal line and the histogram is positive, which points to improving momentum versus the prior downswing. In plain terms, when MACD is above its signal line, it suggests buyers are regaining control and downside pressure is easing. - **Key Resistance**: $20.81 — the 52-week high zone that can act as an overhead supply area if the stock revisits prior peaks - **Key Support**: $11.03 — near the 20-day SMA, a level that often becomes the first "trend support" on pullbacks ## What Does POET Technologies Do? POET Technologies Inc. Common Shares is a design and development company building high-speed optical engines, light source products, and custom optical modules for AI systems and hyperscale data centers. The core of the story is the POET Optical Interposer, a patented platform designed to integrate electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. That matters for the current move because the partnerships being discussed are directly tied to scaling optical connectivity for AI infrastructure, where bandwidth and power efficiency are key constraints. The company operates across the United States, Canada, Singapore and China, and it has also discussed shifting production capacity from China to Malaysia as it scales. ## POET Stock Price Activity Monday Morning **POET Stock Price Activity:** POET Technologies shares were down 4.70% at $15.23 Monday morning, according to Benzinga Pro data. **Read Also: Stock Market Today: Dow, S&P 500, Nasdaq Futures Drop After UAE Nuclear Plant Strike— Regeneron Pharma, NextNRG, ServiceNow In Focus** _Image: Shutterstock_ ### Related Stocks - [POET.US](https://longbridge.com/en/quote/POET.US.md) ## Related News & Research - [Why Poet Technologies stock skyrocketed this week](https://longbridge.com/en/news/286681063.md) - [POET Technologies GAAP EPS of -$0.08 misses by $0.03, revenue of $0.5M beats by $0.25M](https://longbridge.com/en/news/286510324.md) - [POET Technologies Posts Higher Q1 2026 Revenue but Swings to Net Loss as Costs Surge](https://longbridge.com/en/news/286588263.md) - [POET Stock Jumped on $500 Million Deal With Lumilens. Its Financials Have a Long Way to Go.](https://longbridge.com/en/news/286600014.md) - [16:59 ETPOET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm](https://longbridge.com/en/news/286818917.md)